Procter & Gamble Health Ltd (PGHL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 346859, "name": "P & G Health Ltd", "stock_name": "P & G Health Ltd", "full_name": "Procter & Gamble Health Ltd", "name_url": "stocks-analysis/p-g-health", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "6,622.00", "chg": 353.35, "chgp": "5.64%", "dir": 1, "prev_price": "6,268.65", "mcapval": "10,607.00 Cr", "mcap": "Small Cap", "scripcode": 500126, "symbol": "PGHL", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE199A01012", "curr_date": "Jul 09, 03:30 PM", "curr_time": "17:41 PM", "last_traded_at": "Jul 09, 03:30 PM IST", "bse_nse_vol": "55.88 k", "exc_status": "Active", "traded_date": "Jul 09, 2026", "traded_date_str": "2026 07 09", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/p-g-health-346859-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Procter & Gamble Health Ltd Surges 7.82% to Day's High of Rs 6748.25 — Outperforms Sector by 5.73 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-hits-intraday-high-with-782-surge-on-9-july-2026-4095345", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ProcterGambleHe_priceRelatedfactors_4095345.png", "date": "2026-07-09 13:46:37", "description": "The Sensex advanced 0.75% on 09 Jul 2026, but Procter & Gamble Health Ltd outpaced the broader market with a robust 7.82% gain, touching an intraday high of Rs 6748.25. This 5.73 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift." }, { "title": "Broad-Based Technical Strength Lifts Procter & Gamble Health Ltd to 52-Week High of Rs 6748.25", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-hits-new-52-week-high-at-rs674825-4095343", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ProcterGambleHe_priceRelatedfactors_4095343.png", "date": "2026-07-09 13:35:12", "description": "With a decisive surge to Rs 6748.25 on 09 Jul 2026, Procter & Gamble Health Ltd has reached a fresh 52-week high, outperforming its sector by 5.41% and extending a two-day winning streak that has delivered a 7.15% return. This milestone caps an 18.23% gain over the past year, comfortably outpacing the Sensex’s decline of 7.77% during the same period." }, { "title": "Procter & Gamble Health Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-technical-momentum-shifts-signal-bullish-outlook-4094302", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ProcterGambleHe_technicaldot_4094302.png", "date": "2026-07-09 08:01:45", "description": "Procter & Gamble Health Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a confluence of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest an improving price momentum despite some mixed signals on weekly and monthly timeframes." }, { "title": "Procter & Gamble Health Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4093000", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ProcterGambleHe_mojoScore_4093000.png", "date": "2026-07-08 08:12:37", "description": "Procter & Gamble Health Ltd (P&G Health) has seen its investment rating downgraded from Buy to Hold as of 7 July 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite strong financial performance and robust management efficiency, evolving market dynamics and technical signals have prompted a more cautious stance." }, { "title": "Procter & Gamble Health Ltd Sees Technical Momentum Shift Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-sees-technical-momentum-shift-amid-mixed-signals-4092759", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ProcterGambleHe_technicaldot_4092759.png", "date": "2026-07-08 08:01:45", "description": "Procter & Gamble Health Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a day decline of 1.10%, the stock’s mixed technical indicators suggest a nuanced outlook for investors navigating this evolving landscape." }, { "title": "Procter & Gamble Health Ltd Gains 1.80%: 3 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-gains-180-3-key-factors-driving-the-week-4089248", "imagepath": "", "date": "2026-07-05 09:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>29 Jun:</strong> Technical momentum shifts signal mildly bullish outlook</p>\n <p><strong>2 Jul:</strong> Mojo Grade upgraded to Buy following strong technical and financial results</p>\n <p><strong>2 Jul:</strong> Technical momentum further upgraded to bullish stance</p>\n <p><strong>3 Jul:</strong> Week closes at Rs.6,361.45 with a slight dip of -1.54%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,248.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</d..." }, { "title": "Procter & Gamble Health Ltd Upgraded to Buy on Strong Technical and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-4084181", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ProcterGambleHe_mojoScore_4084181.png", "date": "2026-07-02 08:19:14", "description": "Procter & Gamble Health Ltd has seen its investment rating upgraded from Hold to Buy, driven by a marked improvement in technical indicators, robust financial results, and a favourable valuation outlook. The company’s strong quarterly performance, coupled with bullish technical trends and solid management efficiency, has prompted analysts to revise their stance on this small-cap pharmaceutical player." }, { "title": "Procter & Gamble Health Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-technical-momentum-shifts-signal-bullish-outlook-4083613", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ProcterGambleHe_technicaldot_4083613.png", "date": "2026-07-02 08:02:49", "description": "Procter & Gamble Health Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by a combination of positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, alongside a robust price performance that outpaces the broader market benchmarks." }, { "title": "Procter & Gamble Health Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-amp-gamble-health-ltd-is-rated-hold-4081652", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ProcterGambleHe_mojoScore_4081652.png", "date": "2026-07-01 10:10:03", "description": "Procter & Gamble Health Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 01 July 2026, providing investors with the most up-to-date insight into the company’s performance and outlook." } ], "total": 183, "sid": "346859", "stock_news_url": "https://www.marketsmojo.com/news/procter-gamble-health-346859" }, "announcements": [ { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "03-Jul-2026", "details": "Dear Sir Please find attached signed certificate for confirming compliance under Regulation 74 (5) of the SEBI (DP) Regulations for the quarter ended June 30 2026.", "source": "BSE" }, { "caption": "Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited (The Company)", "datetime": "26-Jun-2026", "details": "Dear Sir Please find attached communication in respect of deduction of TDS on the amount of final dividend income from the Company if approved by the shareholders at the ensuing AGM.", "source": "BSE" }, { "caption": "Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 6 2026", "datetime": "26-Jun-2026", "details": "Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve Dear Sir In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday August 6 2026 inter alia to consider and approve unaudited Financial Results for the quarter ended June 30 2026. Kindly take the same on record.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "06 Aug 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Procter & Gamble Health Ltd has declared <strong>1100%</strong> dividend, ex-date: 12 Feb 26", "dt": "2026-02-12", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

29 Jun: Technical momentum shifts signal mildly bullish outlook

2 Jul: Mojo Grade upgraded to Buy following strong technical and financial results

2 Jul: Technical momentum further upgraded to bullish stance

3 Jul: Week closes at Rs.6,361.45 with a slight dip of -1.54%

Week Open

Rs.6,248.75

Week CloseRead full news article

Procter & Gamble Health Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-07-02 08:19:14

Procter & Gamble Health Ltd has seen its investment rating upgraded from Hold to Buy, driven by a marked improvement in technical indicators, robust financial results, and a favourable valuation outlook. The company’s strong quarterly performance, coupled with bullish technical trends and solid management efficiency, has prompted analysts to revise their stance on this small-cap pharmaceutical player.

Read full news article

Procter & Gamble Health Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-07-02 08:02:49

Procter & Gamble Health Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by a combination of positive signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, alongside a robust price performance that outpaces the broader market benchmarks.

Read full news article

Procter & Gamble Health Ltd is Rated Hold

2026-07-01 10:10:03

Procter & Gamble Health Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 08 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 01 July 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article